Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
4.900
+0.360 (7.93%)
At close: Apr 7, 2026
Market Cap34.28M +65.6%
Revenue (ttm)71.67M +8.4%
Net Income904.36K
EPS0.13
Shares Out7.00M
PE Ratio37.90
Forward PE13.59
Dividendn/a
Ex-Dividend Daten/a
Volume20,088
Average Volume12,056
Open4.540
Previous Close4.540
Day's Range4.540 - 5.000
52-Week Range2.800 - 6.000
Beta0.17
RSI50.88
Earnings DateApr 22, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 394
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements